Add to Calendar 3/27/2019 8:15:00 AM 3/28/2019 2:30:00 PM 2019 Annual Meeting: State of Possible Conference
This year’s Annual Meeting is now the State of Possible Conference where we'll celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk. We'll also have a networking reception, the State of Possible Celebration, immediately following Day 1 of the conference, where we'll have great food, drinks, a DJ. Attendees will also have access to the exhibits at the Museum of Science. Join us as we celebrate the State of Possible!
 

If you haven’t attended our Annual Meeting before, it is the premier east coast life sciences conference and this year’s event is better than ever. With speakers like Katrine Bosley, John Maraganore, Jeremy Levin, George Church, and more, we have some of the brightest names in biotech talking about the issues impacting our industry. See our incredible lineup of speakers and topics below. Online registration closes at noon on Tuesday, March 26th. Walk-in registrations will be available on-site. 

 Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142
Associate, Omega Funds
Johnny joined Omega Funds in 2018, where he focuses on private company investing, with a focus on new therapeutic modalities. He is especially interested in gene and cell therapies due to his previous work in the space. Prior to Omega, Johnny completed his PhD at Harvard University as a National Defense Science and Engineering Graduate Fellow and National Science Foundation Graduate Research Fellow in the labs of David Liu and George Church. His thesis project focused on using directed evolution to evolve new gene editing tools and was published in Nature. Previously, he also interned with Vida Ventures, PureTech Health, RA Capital, and Genentech. Johnny earned his MPhil as a Gates Cambridge Scholar from the University of Cambridge and his AB summa cum laude in Chemical and Physical Biology from Harvard University.

Brought to you by